Design and Setup of a New HPGe Detector Based Body Counter Capable of Detecting Also Low Energy Photon Emitters

The present work describes the development of a new body-counter system based on HPGe detectors and installed at IVM of KIT. The goal, achieved, was the improvement of the ability to detect internal contaminations in the human body, especially the ones concerning low-energy emitters and multiple nuclides. The development of the system started with the characterisation of detectors purchased for this specific task, with the optimisation of the different desired measurement configurations following and ending with the installation and check of the results. A new software has been developed to handle the new detectors.

IBeacon: evoluzione della microgeolocalizzazione

Obiettivo di questa tesi è l'analisi e l'approfondimento di una tecnologia di nuova generazione che prende il nome di iBeacon. Basata sulla localizzazione di prossimità (wireless) a bassi consumi energetici e sviluppata da Apple, l'iBeacon sfrutta il protocollo Bluetooth Low Energy con il quale riesce ad utilizzare al meglio l'energia, permettendo alle batterie dei dispositivi che lo implementano di durare molto più a lungo. In questa argomentazione, vengono elencate e descritte alcune tecniche di comunicazione wireless a medio-corto raggio (Wi-Fi, Infrarosso, RFID, NFC, Bluetooth, BLE), che utilizzano lo scambio di informazioni senza fili, descrivendone una breve storia, dalla loro evoluzione nel tempo e nei modi, ad alcune caratteristiche di utilizzo. L'argomentazione poi focalizzerà l'attenzione sui metodi di localizzazione utilizzati dall'iBeacon, fornendone le funzionalità e le caratteristiche principali di questa nuova tecnologia e discutendone i vantaggi, i limiti tecnologici e di sviluppo del protocollo, fino a delineare alcune soluzioni per quanto riguarda le soglie di sicurezza e di privacy. L'analisi poi confronterà l'iBeacon con i maggiori antagonisti che utilizzano questa tecnica di microgeolocalizzazione (NFC, EddyStone). Si cercherà inoltre di delineare in maniera più dettagliata le specifiche tecniche che costituiscono questa nuova tecnologia di prossimità, dal protocollo di comunicazione alla componentistica hardware. Successivamente verrà descritto come un dispositivo iOS si interfaccia con un iBeacon, delineandone le API e il setup e mostrando i diversi passaggi per la creazione di un prototipo di applicazione. Si cercherà infine di pianificare, progettare e costruire una rete con iBeacon. Come ultima analisi, si prenderà in esame la relazione tra l'iBeacon e l'Internet of Things (IoT), e gli sviluppi che potrà portare all'evoluzione del Marketing di Prossimità, mostrando un esempio concreto di utilizzo efficace di questa innovativa tecnologia (EXPO 2015).

Monte Carlo dose calculation improvements for low energy electron beams using eMC

The electron Monte Carlo (eMC) dose calculation algorithm in Eclipse (Varian Medical Systems) is based on the macro MC method and is able to predict dose distributions for high energy electron beams with high accuracy. However, there are limitations for low energy electron beams. This work aims to improve the accuracy of the dose calculation using eMC for 4 and 6 MeV electron beams of Varian linear accelerators. Improvements implemented into the eMC include (1) improved determination of the initial electron energy spectrum by increased resolution of mono-energetic depth dose curves used during beam configuration; (2) inclusion of all the scrapers of the applicator in the beam model; (3) reduction of the maximum size of the sphere to be selected within the macro MC transport when the energy of the incident electron is below certain thresholds. The impact of these changes in eMC is investigated by comparing calculated dose distributions for 4 and 6 MeV electron beams at source to surface distance (SSD) of 100 and 110 cm with applicators ranging from 6 x 6 to 25 x 25 cm(2) of a Varian Clinac 2300C/D with the corresponding measurements. Dose differences between calculated and measured absolute depth dose curves are reduced from 6% to less than 1.5% for both energies and all applicators considered at SSD of 100 cm. Using the original eMC implementation, absolute dose profiles at depths of 1 cm, d(max) and R50 in water lead to dose differences of up to 8% for applicators larger than 15 x 15 cm(2) at SSD 100 cm. Those differences are now reduced to less than 2% for all dose profiles investigated when the improved version of eMC is used. At SSD of 110 cm the dose difference for the original eMC version is even more pronounced and can be larger than 10%. Those differences are reduced to within 2% or 2 mm with the improved version of eMC. In this work several enhancements were made in the eMC algorithm leading to significant improvements in the accuracy of the dose calculation for 4 and 6 MeV electron beams of Varian linear accelerators.

The Search for Low Energy Conformational Families of Small Peptides: Searching for Active Conformations of Small Peptides in the Absence of a Known Receptor

Breast cancer is the most common cancer among women. Tamoxifen is the preferred drug for estrogen receptor-positive breast cancer treatment, yet many of these cancers are intrinsically resistant to tamoxifen or acquire resistance during treatment. Therefore, scientists are searching for breast cancer drugs that have different molecular targets. Previous work revealed that 8-mer and cyclic 9-mer peptides inhibit breast cancer in mouse and rat model systems, interacting with an unknown receptor, while peptides smaller than eight amino acids did not inhibit breast cancer. We have shown that the use of replica exchange molecular dynamics predicts structure and dynamics of active peptides, leading to the discovery of smaller peptides with full biological activity. These simulations identified smaller peptide analogs with a conserved turn, a β-turn formed in the larger peptides. These analogs inhibit estrogen-dependent cell growth in a mouse uterine growth assay, a test showing reliable correlation with human breast cancer inhibition. We outline the computational methods that were tried and used with the experimental information that led to the successful completion of this research.

The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy

The low-energy β− emitter 161Tb is very similar to 177Lu with respect to half-life, beta energy and chemical properties. However, 161Tb also emits a significant amount of conversion and Auger electrons. Greater therapeutic effect can therefore be expected in comparison to 177Lu. It also emits low-energy photons that are useful for gamma camera imaging. The 160Gd(n,γ)161Gd→161Tb production route was used to produce 161Tb by neutron irradiation of massive 160Gd targets (up to 40 mg) in nuclear reactors. A semiautomated procedure based on cation exchange chromatography was developed and applied to isolate no carrier added (n.c.a.) 161Tb from the bulk of the 160Gd target and from its stable decay product 161Dy. 161Tb was used for radiolabeling DOTA-Tyr3-octreotate; the radiolabeling profile was compared to the commercially available n.c.a. 177Lu. A 161Tb Derenzo phantom was imaged using a small-animal single-photon emission computed tomography camera. Up to 15 GBq of 161Tb was produced by long-term irradiation of Gd targets. Using a cation exchange resin, we obtained 80%–90% of the available 161Tb with high specific activity, radionuclide and chemical purity and in quantities sufficient for therapeutic applications. The 161Tb obtained was of the quality required to prepare 161Tb–DOTA-Tyr3-octreotate. We were able to produce 161Tb in n.c.a. form by irradiating highly enriched 160Gd targets; it can be obtained in the quantity and quality required for the preparation of 161Tb-labeled therapeutic agents.

The ArgoNeuT detector in the NuMI low-energy beam line at Fermilab

The ArgoNeuT liquid argon time projection chamber has collected thousands of neutrino and anti-neutrino events during an extended run period in the NuMI beam-line at Fermilab. This paper focuses on the main aspects of the detector layout and related technical features, including the cryogenic equipment, time projection chamber, read-out electronics, and off-line data treatment. The detector commissioning phase, physics run, and first neutrino event displays are also reported. The characterization of the main working parameters of the detector during data-taking, the ionization electron drift velocity and lifetime in liquid argon, as obtained from through-going muon data complete the present report.